Hensoldt AG
XETRA:HAG
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
33.56
113.8
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
HAG
stock under the Base Case scenario is
63.13
EUR.
Compared to the current market price of 69.3 EUR,
Hensoldt AG
is
Overvalued by 9%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Hensoldt AG.
| US |
|
Raytheon Technologies Corp
NYSE:RTX
|
|
| US |
|
RTX Corp
LSE:0R2N
|
|
| NL |
|
Airbus SE
PAR:AIR
|
|
| US |
|
Boeing Co
NYSE:BA
|
|
| FR |
|
Safran SA
PAR:SAF
|
|
| UK |
|
Rolls-Royce Holdings PLC
LSE:RR
|
|
| US |
|
Lockheed Martin Corp
NYSE:LMT
|
|
| US |
|
General Dynamics Corp
NYSE:GD
|
|
| DE |
|
Rheinmetall AG
XETRA:RHM
|
|
| US |
|
Howmet Aerospace Inc
NYSE:HWM
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Hensoldt AG
Balance Sheet Decomposition
Hensoldt AG
| Current Assets | 2.5B |
| Cash & Short-Term Investments | 532m |
| Receivables | 858m |
| Other Current Assets | 1.1B |
| Non-Current Assets | 2.5B |
| Long-Term Investments | 62m |
| PP&E | 613m |
| Intangibles | 1.8B |
| Other Non-Current Assets | 21m |
| Current Liabilities | 2B |
| Accounts Payable | 509m |
| Other Current Liabilities | 1.5B |
| Non-Current Liabilities | 2.1B |
| Long-Term Debt | 1.5B |
| Other Non-Current Liabilities | 552m |
Free Cash Flow Analysis
Hensoldt AG
| EUR | |
| Free Cash Flow | EUR |
Earnings Waterfall
Hensoldt AG
|
Revenue
|
3.3B
EUR
|
|
Cost of Revenue
|
-2.6B
EUR
|
|
Gross Profit
|
682m
EUR
|
|
Operating Expenses
|
-468m
EUR
|
|
Operating Income
|
214m
EUR
|
|
Other Expenses
|
-141m
EUR
|
|
Net Income
|
73m
EUR
|
HAG Profitability Score
Profitability Due Diligence
Hensoldt AG's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
Score
Hensoldt AG's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
HAG Solvency Score
Solvency Due Diligence
Hensoldt AG's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Score
Hensoldt AG's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HAG Price Targets Summary
Hensoldt AG
According to Wall Street analysts, the average 1-year price target for
HAG
is 95.61 EUR
with a low forecast of 65.65 EUR and a high forecast of 119.7 EUR.
Dividends
Current shareholder yield for
HAG is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
HAG
stock under the Base Case scenario is
63.13
EUR.
Compared to the current market price of 69.3 EUR,
Hensoldt AG
is
Overvalued by 9%.